Helicobacter pylori associated duodenal ulcers occur in patches of gastric metaplasia. The pathogenesis of gastric metaplasia is unclear, but it has been produced in experimental animals by acute injury and has been shown to be present to a greater extent of H pylorn positive subjects. This study aimed to Since the initial identification and isolation of Helicobacter pylori in the early 1 980s,' the importance of this organism in the pathogenesis of duodenal ulceration has become increasingly clear.2 3 H pylori is found in the antrum of more than 95% of patients with duodenal ulcer4 and eradication reduces the relpase rate in an otherwise frequently relapsing condition.5-7
Abstract
Helicobacter pylori associated duodenal ulcers occur in patches of gastric metaplasia. The pathogenesis of gastric metaplasia is unclear, but it has been produced in experimental animals by acute injury and has been shown to be present to a greater extent of H pylorn positive subjects. This study aimed to discover if gastric metaplasia regressed with eradication of H pylori or healing of duodenal ulcers, or both. Thirty two duodenal ulcer patients with Hpylori infection confirmed by biopsy urease test and by antral histological examination were studied. Patients were treated with triple therapy (deNol 240 mg twice daily, amoxycillin 500 mg three times daily, and metronidazole 400 mg three times daily) for two weeks after the first endoscopy and were subsequently re-endoscoped. Three duodenal bulb biopsy specimens were obtained per patient at each endoscopy. Biopsy sections were stained with haematoxylin and eosin to determine the severity of duodenitis, and with diastase periodic acid-Schifflalcian blue to assess the extent of gastric metaplasia. Slides were assessed by two histopathologists unaware of treatment status. H pylorn was eradicated in 63% of subjects and all ulcers were healed at follow up. The median extent of gastric metaplasia at the start of treatment and 6-18 months (median 10) after treatment was compared in the two groups. Gastric metaplasia declined in eradicators from 16% to 8% (p<0-05) while in noneradicators there was no significant change (25% initially and at follow up). A positive relation between extent of gastric metaplasia and duodenal inflammation score was present before treatment (r,=0.74, p<0001) and was unchanged after treatment in the non-eradicator group (rs=0.89, p<0.001). In the eradicator group, however, the inflammation score had significantly declined (p<0.02) and the close relation with gastric metaplasia was no longer present. These results suggest that H pylori itself is at least in part responsible for producing gastric metaplasia of the duodenum. (Gut 1995; 36: 193-197) Keywords: Helicobacter pylori, gastric metaplasia, duodenum.
Since the initial identification and isolation of Helicobacter pylori in the early 1 980s,' the importance of this organism in the pathogenesis of duodenal ulceration has become increasingly clear.2 3 H pylori is found in the antrum of more than 95% of patients with duodenal ulcer4 and eradication reduces the relpase rate in an otherwise frequently relapsing condition. [5] [6] [7] Gastric metaplasia of the duodenum, defined as the presence of groups of gastric mucosal cells within normal duodenal epithelium, is an almost constant feature of duodenal ulcer.8 9 It is also present at the margin of intestinal ulcers in inflammatory bowel diseases10 and is believed to be a nonspecific response to injury." Gastric metaplasia is, however, also present in the proximal duodenum of up to two thirds of non-ulcer dyspepsia patients,'2 13 occurring with equal prevalence in H pylori positive and negative subjects" 12 but having a greater extent in those who are positive.'1 In animal studies, gastric metaplasia induced by mucosal injury is of rapid onset and resolves over a period of a few months,14 showing at least in animal models that it is reversible.
Hpylori only colonises gastric epithelium. It is not found in areas of intestinal metaplasia in the stomach'5 and does not colonise normal duodenal mucosa.9 16 Gastric metaplasia is susceptible to colonisation by H pylori however, resulting in chronic active inflammation, which is believed to be important in the pathogenesis of duodenal ulcer.9 1116 Both healing of duodenal ulcer and resolution of active duodenitis follow eradication of H pylori.5 7 17 The effect of eradicating H pylori on the extent of gastric metaplasia has not been determined.
We aimed to discover if Hpylori itselfmay be responsible for the production of gastric metaplasia of the duodenum by observing whether it regresses after eradication of Hpylori in duodenal ulcer patients.
Subjects and methods

SUBJECTS
Thirty two consecutive subjects with H pylori positive duodenal ulcer undergoing endoscopy for dyspepsia were studied; 24 were male and eight female (median age 48, range All patients were treated with antibiotics (amoxycillin 500 mg three times daily and metronidazole 400 mg three times daily) and colloidal bismuth subcitrate (deNol 240 mg twice daily) for two weeks after the first endoscopy and all were re-endoscoped from 6-18 months (median 10) after treatment; antral and duodenal biopsy specimens were repeated from similar topographical sites. Eradication of H pylori was diagnosed by a negative biopsy urease test and negative results on histological examination.
Ten patients required an additional endoscopy less than six months after treatment because of recurring symptoms. In four no ulcer was detected and antral H pylori was absent on histological testing and on urease test, but in six a persisting ulcer was seen and antral H pylori detected. All six patients were treated with ranitidine 150 mg twice daily for six weeks.
HISTOLOGICAL METHODS
Sections from duodenal biopsy specimens were stained with diastase periodic acid Schifflalcian blue and examined for gastric metaplasia and duodenitis (Figs 1 and 2 ), while antral sections were stained with haematoxylin and eosin to detect H pylori. Histological material was examined by two histopathologists unaware of the clinical details. The severity of duodenitis was graded on a scale of 0-3, corresponding to nil, mild, moderate, and severe mucosal inflammation.18
The extent of gastric type epithelium in the duodenal biopsy specimens (gastric metaplasia) was subjectively scored on a scale of 0-10 (representing 0-100% of the total epithelial surface present19). For both severity of duodenitis and extent of gastric metaplasia, the mean score of the three specimens obtained from the same subject were used.
STATISTICAL METHODS
The extent of gastric metaplasia and duodenal inflammation score for the eradicator and noneradicator groups were calculated as medians. Differences between initial and follow up values were compared within groups by the Wilcoxon signed rank test, and between groups by the Mann-Whitney U test. The relation between gastric metaplasia and duodenitis was determined by Spearman's rank correlation coefficient.
Results
ERADICATION AND ULCER HEALING RATE
H pylori was eradicated in 20 patients and persisted in 12. There was no significant difference between eradicators and non-eradicators with respect to age, sex, length of follow up, smoking or a family history of peptic ulceration (Table) . At the time of re-biopsy no active ulcers were seen, however, in patients who had failed to eradicate H pylori endoscopic evidence of duodenitis was seen in eight of 12 patients and duodenal cap deformities of previous ulceration in six of 12. Ranitidine was required for six patients in the non-eradicator group. There was no significant difference in Figure 4 shows the duodenal inflammation o scores initially and at follow up in the eradicator and non-eradicator groups. There was a 90 significant reduction in duodenal inflammation after H pylori eradication (Wilcoxon signed rank test, p<002). Figure 5 shows the relation between duoFollow up denal inflammation score and the extent of gastric metaplasia. A positive relation was present before treatment (rs=0*74, p<000l) between ( Fig 5A) and at follow up in the non-eradicator )t receiv-group (rs=0.89 p<00l) (Fig 5B) . In the that this eradicator group, however, the same close nced the relation between duodenal inflammation and gastric metaplasia was no longer present at follow up ( Fig 5C) . 
A study of a highly variable feature such as gastric metaplasia can be associated with sampling error. Biopsy of an inflamed part of the duodenal bulb may result in increased detection of gastric metaplasia compared with an adjacent less inflamed area.12 To reduce bias in this study, the endoscopist was unaware of the eradication status of the patients and biopsies were targeted to similar topographical sites. Gastric metaplasia has a patchy distribution in the duodenal bulb and a single anterior duodenal biopsy has been shown to detect 63% of the gastric metaplasia detected by multiple biopsies. 1 1 Three duodenal bulb biopsy specimens, including one from the anterior wall, were used in this study to provide adequate sampling of the extent of gastric metaplasia. A longer period of follow up in our study, might have shown more complete resolution of gastric metaplasia. Animal studies suggest, however, that 10 months of follow up would be expected to be adequate to show maximum resolution.' 4 22 In humans even in the absence of duodenal ulceration, the extent of gastric metaplasia is related to gastric acid output" suggesting that acid itself could lead to the formation of gastric metaplasia. It is possible that gastric metaplasia affords some protection against an acidic, gastric environment within the duodenal cap. This is supported by the finding that the incidence of gastric metaplasia is rare beyond the first part of the duodenum." Other factors such as cigarette smoking, NSAIDs, and male sex are not related to the extent of gastric metaplasia independently of acid output."1 12 Duodenal ulcer patients have significantly raised gastric acid production as well as more extensive gastric metaplasia compared with subjects without duodenal ulcer.23 24 Studies have attempted to assess the effect of decreasing acid production on gastric metaplasia with conflicting results. Wyatt et al25 showed that two years after vagotomy, patients had a lesser extent of gastric metaplasia than a control group about to undergo vagotomy. In contrast, Jonsson et a126 found no reversal of gastric metaplasia two to three years after parietal cell vagotomy. The same study failed to show any effect after the same period of treatment with cimetidine. Similarly, Noach et al 21 found no significant difference in the mean extent of gastric metaplasia between patients taking H2 receptor antagonists for more than a year and subjects not taking these drugs. In our study ranitidine was used in six non-eradicators with persisting duodenal ulcer. No significant difference in the extent of gastric metaplasia was detected between these subjects and noneradicators who had not received ranitidine. It is possible that the degree of acid suppression produced by H2 antagonists, at the doses given in these studies, was insufficient to affect gastric metaplasia.
Our results confirmT that a basal level of gastric metaplasia is present, which is independent of Hpyloni; this is consistent with previous reports implicating possible genetic factors'3 or gastric acid secretion'9 in the formation of gastric metaplasia. There are two possible mechanisms by which H pylori itself could increase this basal level of gastric metaplasia. Firstly, H pylori infection has been shown to increase gastric acid production in duodenal ulcer patients leading to greater duodenal acidity.27 The second possibility is that infection of gastric metaplasia with Hpylori leads to duodenal inflammation, provoking extension of gastric type epithelium as a response to injury. Results from our study support this possibility, as they show a close association between severity of duodenal inflammation and extent of gastric metaplasia, and reduction in both after H pylori eradication. Recent studies, including our own,28 29 
textbook of paediatric gastroenterology. The authors of the chapters are well recognised names in the community of paediatric gastroenterologists, from North America and from the United Kingdom, with one representative from continental Europe. Predictably, all have undertaken their task competently and successfully.
The success of the publication must depend on the choice of topics included. This is good in the main, but at times somewhat specialist. The generalist who sees children with gastrointestinal problems will find the chapters on oral rehydration solution, constipation, food allergy, inflammatory bowel disease, gastro-oesophageal reflux, recurrent abdominal pain, and gastrointestinal bleeding, of great interest and educational value. The chapter on 'when to transplant the liver in children' fits uncomfortably; it is a very interesting question for the paediatric hepatologist or specialist gastroenterologist but of little relevance to the probable readership of the publication. The chapters on the role of gastrointestinal motility studies and of home parenteral nutrition fall in between, probably. The relevance of the book to a reader will depend on the number of children with these problems they see, and I suspect that the book will be most useful to the general paediatrician and not the general gastroenterologist.
In keeping with the ethos of counting credits, I would rate this book as being worth three credits (assuming that most generalists would probably read six chapters, and perhaps spend half an hour on each). By doing this, they are probably learning more than by earning six credits by listening to the same authors giving lectures on the same topics, and in addition they have the book on their shelves afterwards. Paediatricians should put it on their reading list for next term, as should any general gastroenterologist who sees children. An authors' error occurred in the paper by Khulusi et al (Gut 1995; 36: 193-7) . The second sentence under Clinical Methods should read 'One duodenal biopsy was obtained from the ulcer margin and two from the anterior duodenum', and on the same point the second paragraph of the Discussion should re-affirm that the three duodenal bulb biopsy specimens included 'two from the anterior wall'. Some editorial errors occurred in the paper by Mothes et al (Gut 1995; 36: 548-52). The tenth line of the Methods section should read 'was stopped by the addition of 10 ml acetic acid' and not 100 ml. In the legend to Also, 'trypsin' and 'tryptic digestion' has been printed as 'tryptin' and tryptin digestion'
throughout the text.
